How to Move a Research Peptide Business to Compliant Telehealth
If you sell peptides labeled "research use only" or "not for human consumption" and your customers are people, not laboratories, you are carrying more risk than the label suggests. This guide is for founders who want out of that model and into one that can advertise, take payments, and survive scrutiny. It is general education, not legal advice. Talk to healthcare counsel about your specific situation.
The label does not decide what you are selling
FDA looks at intended use, and it reads intended use from everything around the product: product pages, claims, social posts, reviews you repost, and what you sell alongside it. In an August 2026 warning letter to an online peptide seller, FDA treated the research use only and not for human consumption disclaimers as no defense, because the seller's own website described effects in people. The agency also treated bacteriostatic water sold for reconstituting the vials as evidence the products were meant to be injected. You can read the letter itself on fda.gov.
The takeaway for a founder: if a reasonable person would conclude your products are for human use, FDA can treat them as unapproved new drugs, whatever the vial says.
What you cannot carry across
Your inventory does not transfer. Research grade product cannot be relabeled, repackaged, or dispensed to patients. A compliant telehealth brand does not hold drug inventory at all. Licensed pharmacies compound or dispense each prescription for a specific patient after a licensed provider orders it.
Your claims do not transfer either. Copy that promises recovery, fat loss, or anti-aging results is the kind of language FDA cited. A compliant brand educates on conditions and care, and leaves treatment decisions to providers.
Your catalog may shrink. Which peptides a licensed pharmacy may lawfully compound is set by FDA rules that have changed repeatedly and are still under review. Some substances sold as research chemicals cannot currently be compounded for patients at all. The compliant catalog is whatever your pharmacy partners can lawfully prepare at the time, nothing more.
What you can carry across
Your audience, your brand recognition, your understanding of what people in this category want to know, and your ability to create content. Those are real assets. The founders who make this move well treat it as a relaunch with a new operating model, not a label change.
The compliant model, step by step
1. A clinical structure. Non-clinician founders typically own the business through a management services structure, while licensed providers own the clinical decisions. See how the MSO model works.
2. Intake and provider review. Every patient completes a medical intake. A licensed provider reviews it and decides whether any treatment is appropriate. Some patients will be declined, and that is the system working.
3. Licensed pharmacy fulfillment. Prescriptions route to licensed 503A or 503B pharmacies, which ship to the patient. Compounded medications are a legal pathway when the rules allow it, never "FDA approved". See 503A vs 503B explained.
4. LegitScript certification. Meta, Google, and most payment processors expect it for this category. GrowPro files through our LegitScript Enterprise account, and the certification is issued to your company. You own it.
5. Payments in your own name. A merchant account underwritten for telehealth, not a gray-market processor that can disappear overnight.
6. Compliant marketing. No efficacy promises, no before-and-after implications, no implying a peptide is available when it is not.
Start with what is clearly lawful
Many founders coming out of research peptides launch with the verticals where the compliant pathway is established, such as hormone care, testosterone, weight management, and labs, then add peptide offerings only as licensed pharmacies can lawfully support them. That gives the business a stable base that does not depend on a single regulatory decision.
Timing matters
A compliant brand takes time to stand up: entity and clinical structure, pharmacy and provider activation, website and intake, LegitScript, and payments. A standard GrowPro build runs 8 to 12 weeks. Plan the wind-down of research sales with counsel in parallel, rather than running both models side by side under one brand.
Once the compliant brand is live, see how we approach peptide marketing for telehealth brands without the claims that draw FDA attention.
Frequently asked questions
Does a research use only label protect a peptide seller from FDA?
No. FDA judges intended use from the whole picture, including product pages and claims. In an August 2026 warning letter, FDA said research use only and not for human consumption disclaimers did not change its view that the products were drugs intended for human use.
Can I relabel my research peptide inventory and sell it through telehealth?
No. Research grade product cannot be relabeled, repackaged, or dispensed to patients. In a compliant telehealth model the brand holds no drug inventory. Licensed pharmacies compound or dispense each prescription for a specific patient after a licensed provider orders it.
Which peptides can a telehealth brand offer?
Only what licensed pharmacies can lawfully compound at the time. FDA rules on peptide compounding have changed repeatedly and are still under review, and some substances sold as research chemicals cannot currently be compounded for patients. Confirm the current list with your pharmacy partner and healthcare counsel.
Why does selling bacteriostatic water matter?
In its August 2026 warning letter to an online peptide seller, FDA treated bacteriostatic water sold for reconstituting peptide vials as evidence that the products were meant to be injected into people, which supported treating them as unapproved new drugs.
Do I need to be a doctor to run a compliant peptide telehealth brand?
No. Non-clinician founders typically own the business through a management services structure, while licensed providers make every clinical and prescribing decision. Every patient completes an intake that a licensed provider reviews before any treatment is considered.
Who owns the LegitScript certification when GrowPro files it?
Your company does. GrowPro files through our LegitScript Enterprise account, and the certification is issued to your company. Meta, Google, and most payment processors expect it for this category.